Results from Phase 2b study of CETP inhibitor TA-8995 published
3 June 2015 | By Victoria White
Dezima Pharma has announced the publication of the phase 2b TULIP study results with its CETP inhibitor, TA-8995, in patients with mild dyslipidaemia...
List view / Grid view
3 June 2015 | By Victoria White
Dezima Pharma has announced the publication of the phase 2b TULIP study results with its CETP inhibitor, TA-8995, in patients with mild dyslipidaemia...